Evidence map›Paper›PMID 36935926›Full record

ArticlePeerJ2023

Kamal Ahmad Qureshi, Faizul Azam, Muhammad Qaiser Fatmi, Mahrukh Imtiaz, Dinesh Kumar Prajapati, Pankaj Kumar Rai, Mariusz Jaremko, Abdul-Hamid Emwas, Gamal Osman Elhassan

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Kamal Ahmad QureshiDepartment of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah, Al-Qassim, Saudi Arabia.
Faizul AzamDepartment of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unaizah, Al-Qassim, Saudi Arabia.
Muhammad Qaiser FatmiDepartment of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan.
Mahrukh ImtiazDepartment of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan.
Dinesh Kumar PrajapatiDepartment of Biotechnology, Faculty of Biosciences, Invertis University, Bareilly, Uttar Pradesh, India.
Pankaj Kumar RaiDepartment of Biotechnology, Faculty of Biosciences, Invertis University, Bareilly, Uttar Pradesh, India.
Mariusz JaremkoSmart-Health Initiative (SHI) and Red Sea Research Center (RSRC), Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Jeddah, Saudi Arabia.
Abdul-Hamid EmwasCore Labs, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
Gamal Osman ElhassanDepartment of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah, Al-Qassim, Saudi Arabia.
Qassim University · SACOMSATS University Islamabad · PKInvertis University · INKing Abdullah University of Science and Technology · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multidrug-resistant tuberculosis (MDR-TB) is one of the world's most devastating contagious diseases and is caused by the MDR- Methods: The anti-TB activity of the isolated actinomycins was assessed Results: Conclusion: In conclusion, our results suggest that both actinomycins X

Indexed as

Antitubercular AgentsTuberculosis, Multidrug-ResistantBCG VaccineDactinomycinHumansMolecular Docking SimulationProtein Kinasesactinomycin XAntitubercular AgentsBCG VaccineDactinomycinProtein KinasesActinomycinAnti-TB drugMolecular dockingProtein kinase PknBStreptomyces

Identifiers

PMID36935926
PMCPMC10022501
OpenAlexW4323556839

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read58
identifiers read12
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.